Inhibition of homologue of Slimb (HOS) function sensitizes human melanoma cells for apoptosis.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 10537278.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Homologue of Slimb (HOS)/beta-transducin repeats containing proteins up-regulate nuclear factor kappaB activity by targeting its inhibitor (IkappaB) for ubiquitination and subsequent degradation. We investigated whether inhibition of HOS function may modulate apoptosis in human melanoma cells. Forced expression of the dominant negative HOSdeltaF construct inhibited IkappaB degradation and led to sensitization of melanoma cells to apoptosis induced by tumor necrosis factor alpha with cycloheximide, as well as by cisplatin and ionizing and UV irradiation. These data indicate that HOS plays an important role in controlling the IkappaB-dependent apoptotic pathways in human melanoma.
Medical subject headings
- Apoptosis
- Carrier Proteins
- Melanoma
- NF-kappa B
- Trans-Activators
- beta-Transducin Repeat-Containing Proteins